CLINICAL AND PHARMACOECONOMIC ANALYSIS OF FIRST- AND SECOND-LINE THERAPY WITH BRUTON TYRO-SINE KINASE INHIBITORS FOR CHRONICLYMPHOCYTIC LEUKEMIA IN KAZAKHSTAN
L. Turgunova; A. Klodzinskiy; M. Butyugina; I. Pivovarova; V. Kemaykin; A. Karabekov; M. Khudaibergenova